FDA
Options Smart Investment Report: Novo Nordisk's call order surges over 8 times; oral weight loss drug receives FDA approval.
I. Overview of US Stock Index Options Trading volume in the US stock index options market is currently declining, and t...
Stock
2026-01-12
The first oral weight-loss drug has received FDA approval! Novo Nordisk shares surge nearly 10% in after-hours trading.
With the approval of the first GLP-1 oral weight-loss drug by US regulators Novo Nordisk , the Danish pharmaceutical gi...
Stock
2026-01-12
